The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 08 2023
25 08 2023
Historique:
received:
17
04
2021
accepted:
29
07
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
25
8
2023
Statut:
epublish
Résumé
Clinical importance of time length from initiation under treat-to-target (T2T) strategy to acquisition of clinical remission (TL) in treating patients with rheumatoid arthritis (RA) on disease activity control, daily activities, and quality of life maintenance was investigated. In patients who achieved Boolean remission once or more, relationship between TL and patients' background data at initiation, and relationship between TL and mean simplified disease activity score (SDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) score, pain score with visual analog scale (PS-VAS), Sharp/van der Heijde Score (SHS) and quality of life score (QOLS) at the first remission and thereafter were evaluated statistically. Patients were divided into two groups whether TL was within 6 months or longer (G ≤ 6 and G > 6). Change of the parameters and Boolean remission rate (BRR) after the first remission between the two groups were compared statistically. In 465 patients, TL correlated significantly with the SDAI score, the HAQ score, PS-VAS, SHS, and the QOLS after the remission. The SDAI score and the BRR after the remission were significantly better in the G ≤ 6 than in the G > 6. TL is an important key to guarantee good and stable clinical course in treating under T2T.
Identifiants
pubmed: 37626142
doi: 10.1038/s41598-023-39711-4
pii: 10.1038/s41598-023-39711-4
pmc: PMC10457332
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13908Informations de copyright
© 2023. Springer Nature Limited.
Références
Arthritis Rheum. 1999 Sep;42(9):1854-60
pubmed: 10513799
Rheumatology (Oxford). 2020 Jan 1;59(1):9-11
pubmed: 31630174
Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S45-S48
pubmed: 27762194
Ann Rheum Dis. 2022 Feb;81(2):296-299
pubmed: 34509991
Arthritis Rheum. 2008 Sep;58(9):2622-31
pubmed: 18759299
Lancet. 2007 Dec 1;370(9602):1861-74
pubmed: 17570481
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Semin Arthritis Rheum. 2020 Apr;50(2):276-284
pubmed: 31590930
Arthritis Rheum. 2006 Sep;54(9):2784-92
pubmed: 16947781
Ann Rheum Dis. 2009 Jun;68(6):823-7
pubmed: 18593759
Ann Rheum Dis. 2019 Dec;78(12):1609-1615
pubmed: 31434637
Ann Rheum Dis. 2016 Jan;75(1):3-15
pubmed: 25969430
Arthritis Rheum. 2011 Mar;63(3):573-86
pubmed: 21294106
Arthritis Rheum. 2009 May;60(5):1242-9
pubmed: 19404938
Rheumatology (Oxford). 2003 Feb;42(2):244-57
pubmed: 12595618
Arthritis Rheum. 2001 Sep;44(9):2009-17
pubmed: 11592361
Nat Rev Rheumatol. 2017 Jul;13(7):443-448
pubmed: 28615732
Arthritis Rheum. 2004 Jan;50(1):36-42
pubmed: 14730597
Rheumatology (Oxford). 2014 Mar;53(3):482-90
pubmed: 24241035
Lancet. 1989 May 13;1(8646):1036-8
pubmed: 2565997
J Rheumatol. 2014 Sep;41(9):1755-60
pubmed: 25086073
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-22-8
pubmed: 17083758
Ann Rheum Dis. 2020 Apr;79(4):445-452
pubmed: 32024651
Arthritis Rheum. 2004 Jul;50(7):2082-93
pubmed: 15248205
Ann Rheum Dis. 2012 Jun;71(6):845-50
pubmed: 22210852
Arthritis Rheum. 2006 Mar;54(3):702-10
pubmed: 16508926
Rheumatology (Oxford). 2009 Sep;48(9):1114-21
pubmed: 19589891
Ann Rheum Dis. 2017 Jun;76(6):960-977
pubmed: 28264816
Rheumatology (Oxford). 2004 Jul;43(7):906-14
pubmed: 15113999
Arthritis Rheum. 2005 Sep;52(9):2625-36
pubmed: 16142705
J Rheumatol. 1994 Mar;21(3):425-9
pubmed: 7516430
Ann Rheum Dis. 2010 Apr;69(4):631-7
pubmed: 20215140
Best Pract Res Clin Rheumatol. 2007 Aug;21(4):663-75
pubmed: 17678828
Rheumatology (Oxford). 2018 Nov 1;57(11):2022-2031
pubmed: 30053199
Clin Rheumatol. 2019 Nov;38(11):3033-3039
pubmed: 31270696
Clinicoecon Outcomes Res. 2015 Oct 07;7:505-20
pubmed: 26504403
Arthritis Res Ther. 2019 Jul 5;21(1):164
pubmed: 31277720
Arthritis Res Ther. 2019 Nov 10;21(1):231
pubmed: 31707982
Clin Rheumatol. 2010 Nov;29(11):1317-22
pubmed: 20645116
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
Semin Arthritis Rheum. 2020 Aug;50(4):624-626
pubmed: 32502726
Rheumatology (Oxford). 2007 Jun;46(6):975-9
pubmed: 17341506
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Br J Rheumatol. 1992 Aug;31(8):519-25
pubmed: 1386548
Ann Rheum Dis. 2010 Apr;69(4):638-643
pubmed: 20237123